Literature DB >> 2253313

Tumor progression: potential role of unstable genomic changes.

R P Hill1.   

Abstract

It is generally accepted that the genome of tumor cells is less stable than that of most normal cells, and it has been hypothesized that this genomic instability is probably involved in the process of tumor progression. However, the rate of occurrence of classical spontaneous mutations in tumor cells is too low to account for the rapid changes that can occur during tumor progression. Thus it is likely that other types of changes, such as gene amplification, must be involved in tumor progression. Gene amplification has been extensively studied in relation to the development of drug resistance. Low levels of amplification can occur spontaneously in tumor cell populations, but the amplified genes are lost rapidly unless prolonged selective pressure is applied. This paper argues that unstable increases in the expression of genes, probably as a result of low levels of amplification, may be all that is required for some of the stages in the process of tumor progression. This may be particularly true for the steps involved in metastasis formation. Recent studies have suggested that microenvironmental conditions known to occur in tumors (hypoxia, nutrient deprivation) may induce gene amplification in cells. This suggests the possibility that such conditions could promote tumor progression.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2253313     DOI: 10.1007/bf00046340

Source DB:  PubMed          Journal:  Cancer Metastasis Rev        ISSN: 0167-7659            Impact factor:   9.264


  59 in total

1.  DNA amplification is rare in normal human cells.

Authors:  J A Wright; H S Smith; F M Watt; M C Hancock; D L Hudson; G R Stark
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

2.  Altered expression of NM23, a gene associated with low tumor metastatic potential, during adenovirus 2 Ela inhibition of experimental metastasis.

Authors:  P S Steeg; G Bevilacqua; R Pozzatti; L A Liotta; M E Sobel
Journal:  Cancer Res       Date:  1988-11-15       Impact factor: 12.701

3.  Involvement of soybean agglutinin binding cells in the lymphatic metastasis of the R3230AC rat mammary adenocarcinoma.

Authors:  N D Buckley; S A Carlsen
Journal:  Cancer Res       Date:  1988-03-15       Impact factor: 12.701

Review 4.  Tumor heterogeneity.

Authors:  G H Heppner
Journal:  Cancer Res       Date:  1984-06       Impact factor: 12.701

Review 5.  Cancer metastasis. Organ colonization and the cell-surface properties of malignant cells.

Authors:  G L Nicolson
Journal:  Biochim Biophys Acta       Date:  1982-12-21

6.  The selection and characterization of an invasive variant of the B16 melanoma.

Authors:  I R Hart
Journal:  Am J Pathol       Date:  1979-12       Impact factor: 4.307

7.  Generation of drug-resistant variants in metastatic B16 mouse melanoma cell lines.

Authors:  C Cillo; J E Dick; V Ling; R P Hill
Journal:  Cancer Res       Date:  1987-05-15       Impact factor: 12.701

Review 8.  Genetic instability of cancer. Why a metastatic tumor is unstable and a benign tumor is stable.

Authors:  J P Volpe
Journal:  Cancer Genet Cytogenet       Date:  1988-08

9.  Increasing metastatic potential is associated with increasing genetic instability of clones isolated from murine neoplasms.

Authors:  M A Cifone; I J Fidler
Journal:  Proc Natl Acad Sci U S A       Date:  1981-11       Impact factor: 11.205

10.  Human multidrug-resistant cell lines: increased mdr1 expression can precede gene amplification.

Authors:  D W Shen; A Fojo; J E Chin; I B Roninson; N Richert; I Pastan; M M Gottesman
Journal:  Science       Date:  1986-05-02       Impact factor: 47.728

View more
  21 in total

1.  CINSARC: a new look into an old concept gives hope for new treatments for synovial sarcomas.

Authors:  Bertha A Brodin
Journal:  Transl Pediatr       Date:  2013-04

Review 2.  Novel vascular targeting/disrupting agents: combretastatin A4 phosphate and related compounds.

Authors:  Matthew M Cooney; Jose Ortiz; Ronald M Bukowski; Scot C Remick
Journal:  Curr Oncol Rep       Date:  2005-03       Impact factor: 5.075

3.  p-Glycoprotein expression as a predictor of breast cancer recurrence.

Authors:  S Gregorcyk; Y Kang; D Brandt; P Kolm; G Singer; R R Perry
Journal:  Ann Surg Oncol       Date:  1996-01       Impact factor: 5.344

4.  Clonal heterogeneity in plasminogen activator activity produced by two murine tumor cell lines.

Authors:  L H Brail; R P Hill
Journal:  Clin Exp Metastasis       Date:  1995-11       Impact factor: 5.150

5.  Hypoxia-induced tetraploidisation of a diploid human melanoma cell line in vitro.

Authors:  E K Rofstad; N M Johnsen; H Lyng
Journal:  Br J Cancer Suppl       Date:  1996-07

Review 6.  The role of cadmium and nickel in estrogen receptor signaling and breast cancer: metalloestrogens or not?

Authors:  Natalie B Aquino; Mary B Sevigny; Jackielyn Sabangan; Maggie C Louie
Journal:  J Environ Sci Health C Environ Carcinog Ecotoxicol Rev       Date:  2012       Impact factor: 3.781

Review 7.  Molecular chemotherapy for breast cancer.

Authors:  A Patterson; A L Harris
Journal:  Drugs Aging       Date:  1999-02       Impact factor: 3.923

8.  MicroRNA regulation of DNA repair gene expression in hypoxic stress.

Authors:  Meredith E Crosby; Ritu Kulshreshtha; Mircea Ivan; Peter M Glazer
Journal:  Cancer Res       Date:  2009-01-13       Impact factor: 12.701

Review 9.  An imaging-based tumour growth and treatment response model: investigating the effect of tumour oxygenation on radiation therapy response.

Authors:  Benjamin Titz; Robert Jeraj
Journal:  Phys Med Biol       Date:  2008-08-01       Impact factor: 3.609

10.  Alterations in phenotypic biochemical markers in bladder epithelium during tumorigenesis.

Authors:  J Y Rao; G P Hemstreet; R E Hurst; R B Bonner; P L Jones; K W Min; Y Fradet
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.